These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9356819)

  • 1. Unusual prolonged hypocalcemia due to foscarnet in a patient with AIDS.
    Guillaume MP; Karmali R; Bergmann P; Cogan E
    Clin Infect Dis; 1997 Oct; 25(4):932-3. PubMed ID: 9356819
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind placebo-controlled crossover trial of intravenous magnesium sulfate for foscarnet-induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection.
    Huycke MM; Naguib MT; Stroemmel MM; Blick K; Monti K; Martin-Munley S; Kaufman C
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2143-8. PubMed ID: 10898688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypocalcemia in a patient with the acquired immunodeficiency syndrome treated only with foscarnet].
    Kindelan JM; García-Lázaro M; García-Herola A; Jurado R
    Med Clin (Barc); 1994 Oct; 103(14):559. PubMed ID: 7799675
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine effects of HIV infection.
    Chakrabarti J
    N Engl J Med; 1993 Mar; 328(12):889-90. PubMed ID: 8441444
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of crystals in kidneys of AIDS patients treated with foscarnet.
    Maurice-Estepa L; Daudon M; Katlama C; Jouanneau C; Sazdovitch V; Lacour B; Beaufils H
    Am J Kidney Dis; 1998 Sep; 32(3):392-400. PubMed ID: 9740154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foscarnet-induced hypercalcaemia in AIDS.
    Gayet S; Ville E; Durand JM; Mars ME; Morange S; Kaplanski G; Gallais H; Soubeyrand J
    AIDS; 1997 Jul; 11(8):1068-70. PubMed ID: 9223751
    [No Abstract]   [Full Text] [Related]  

  • 7. Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet.
    Omar RF; Dusserre N; Désormeaux A; Poulin L; Tremblay M; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1973-8. PubMed ID: 8540701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A penile ulceration in a patient with the acquired immunodeficiency syndrome. Foscarnet-induced penile ulceration.
    Fitzgerald E; Goldman HM; Miller WG; Purcell SM
    Arch Dermatol; 1995 Dec; 131(12):1449, 1452. PubMed ID: 7492139
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrogenic diabetes insipidus associated with foscarnet--a case report.
    Conn J; Colman P; Brown G; Street A; Bate K
    J Antimicrob Chemother; 1996 Jun; 37(6):1179-81. PubMed ID: 8836823
    [No Abstract]   [Full Text] [Related]  

  • 10. A brighter future for the AIDS patient.
    Lowell E; Van Tassell B
    Insight; 2002; 27(4):95-6. PubMed ID: 12520982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case for diagnosis: penile ulcer induced by foscarnet].
    Papini M; Bruni PL
    Ann Dermatol Venereol; 1996; 123(10):679-80. PubMed ID: 9615134
    [No Abstract]   [Full Text] [Related]  

  • 12. Foscarnet and AIDS-associated Kaposi's sarcoma.
    Cordero E; López-Cortés LF; Viciana P; Alarcón A; Pachón J
    AIDS; 1997 Nov; 11(14):1787-8. PubMed ID: 9386820
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytomegalovirus pneumonia in patients with AIDS treated foscarnet. Our experience].
    Terra L; Pellicanò S; Calzone R; Mandica D; Milano M
    Minerva Med; 1997 Oct; 88(10):411-3. PubMed ID: 9417536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in treatment for cytomegalovirus retinitis.
    Bowers M
    BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foscarnet-induced penile ulceration.
    Torres T; Fernandes I; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2011; 20(1):39-40. PubMed ID: 21879205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet.
    Ota R; Hirata A
    J Chemother; 2021 Dec; 33(8):539-546. PubMed ID: 34060436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group.
    Carosi G; Castelli F; Lernestedt JO; Antoniazzi E; Gerna G
    AIDS; 1997 Feb; 11(2):258-60. PubMed ID: 9030380
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination therapy improves CMV treatment.
    AIDS Alert; 1996 Mar; 11(3):32-3. PubMed ID: 11363244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimising the dosage-limiting toxicities of foscarnet induction therapy.
    Jayaweera DT
    Drug Saf; 1997 Apr; 16(4):258-66. PubMed ID: 9113493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic cytomegalovirus infection: changes in serum calcium and magnesium levels with foscarnet treatment].
    Marzal-Alfaro MB; Manrique-Rodríguez S; Alcaraz Romero A; García San Prudencio M; Fernández-Llamazares CM
    An Pediatr (Barc); 2015 Jan; 82(1):e170-4. PubMed ID: 24785445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.